Skip to main content

Closed

BOLT: Bolt Biotherapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.1% / yr

Operating margin-463.4%

ROIC-69.0%

Financially safe

Stretched

Debt / equity1.13×

Interest coverage0.0×

Current ratio3.51×

Bolt Biotherapeutics, Inc.

BOLTNASDAQ Global Select·USD·Closed

Bolt Biotherapeutics, Inc.

BOLTNASDAQ·USD·Closed

$3.99

+2.57%

$3.99

+$0.10 (2.57%)

52W Range

7thpctl

Volume

0.78×avg

Mkt Cap

7.67MUSD

P/E

-0.3TTM

Div Yield

–ann

52W Range

7thpctl

Volume

0.78×avg

Market Cap

7.67MUSD

P/E Ratio

-0.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings